| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Amanda Forde | Q95949135 |
| Colin Hill | Q37830656 | ||
| P2093 | author name string | Amanda Forde | |
| P2860 | cites work | A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy | Q22061813 |
| Bacteriophage therapy | Q24550616 | ||
| Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics | Q26740597 | ||
| From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea | Q38838727 | ||
| Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections | Q38989510 | ||
| Bacterial DNA Methylation and Methylomes | Q39003514 | ||
| Delivering phage therapy per os: benefits and barriers | Q39019401 | ||
| Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages. | Q39023156 | ||
| Phages in the Human Body | Q39249579 | ||
| Ménage à trois in the human gut: interactions between host, bacteria and phages | Q39276552 | ||
| Embracing the enemy: the diversification of microbial gene repertoires by phage-mediated horizontal gene transfer | Q39319547 | ||
| Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. | Q39422844 | ||
| Stable core virome despite variable microbiome after fecal transfer | Q40416440 | ||
| Exploring the contribution of bacteriophages to antibiotic resistance. | Q40455433 | ||
| Phages rarely encode antibiotic resistance genes: a cautionary tale for virome analyses | Q40689920 | ||
| Unexploited opportunities for phage therapy. | Q40964122 | ||
| Pros and cons of phage therapy | Q41083979 | ||
| Assessment of viral community functional potential from viral metagenomes may be hampered by contamination with cellular sequences. | Q41845229 | ||
| Inhibition of biofilm formation by T7 bacteriophages producing quorum-quenching enzymes. | Q41847965 | ||
| Regulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines | Q48511190 | ||
| Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota | Q56220182 | ||
| Bacteriophages and transplantation tolerance | Q82674431 | ||
| Freshwater Metaviromics and Bacteriophages: A Current Assessment of the State of the Art in Relation to Bioinformatic Challenges | Q26745441 | ||
| Fecal microbiota transplantation: in perspective | Q26765214 | ||
| Bacteriophage orphan DNA methyltransferases: insights from their bacterial origin, function, and occurrence | Q26825752 | ||
| Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota | Q26827355 | ||
| Phage cocktails and the future of phage therapy | Q26995797 | ||
| Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases | Q28069939 | ||
| Gut Microbiota in Health and Disease | Q29616812 | ||
| Improved bacteriophage genome data is necessary for integrating viral and bacterial ecology | Q30697825 | ||
| Metagenomic Approaches to Assess Bacteriophages in Various Environmental Niches | Q32183798 | ||
| Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers. | Q33726692 | ||
| Phage neutralization by sera of patients receiving phage therapy | Q33828266 | ||
| A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes | Q33950908 | ||
| Viruses in the faecal microbiota of monozygotic twins and their mothers | Q34058882 | ||
| Disease-specific alterations in the enteric virome in inflammatory bowel disease | Q34459570 | ||
| Novel "superspreader" bacteriophages promote horizontal gene transfer by transformation | Q34549493 | ||
| Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. | Q34996099 | ||
| Phages in nature | Q35029210 | ||
| The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth | Q35952871 | ||
| Transfer of Viral Communities between Human Individuals during Fecal Microbiota Transplantation | Q35973063 | ||
| The Janus-Face of Bacteriophages across Human Body Habitats | Q36060279 | ||
| Fecal Transplants: What Is Being Transferred? | Q36073899 | ||
| Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. | Q36198872 | ||
| Transmission of viruses via our microbiomes | Q36212324 | ||
| Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome | Q37009655 | ||
| Healthy human gut phageome | Q37264294 | ||
| Bacteriophage and their lysins for elimination of infectious bacteria | Q37470848 | ||
| A Review of Phage Therapy against Bacterial Pathogens of Aquatic and Terrestrial Organisms | Q37727839 | ||
| Communication between viruses guides lysis-lysogeny decisions. | Q37735689 | ||
| Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome | Q38766504 | ||
| Bacteriophage therapy: a regulatory perspective | Q38805538 | ||
| Information Phage Therapy Research Should Report | Q38806701 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 412-418 | |
| P577 | publication date | 2017-12-19 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Phages of life - the path to pharma | |
| P478 | volume | 175 |
| Q92454948 | Application of the Phage Lysin Ply5218 in the Treatment of Streptococcus suis Infection in Piglets |
| Q56888912 | Bacteriophages: Protagonists of a Post-Antibiotic Era |
| Q92541418 | Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections |
| Q90479512 | Development of a Bacteriophage Cocktail to Constrain the Emergence of Phage-Resistant Pseudomonas aeruginosa |
| Q64935159 | Human gut microbiome: hopes, threats and promises. |
| Q58758208 | Insights into the Human Virome Using CRISPR Spacers from Microbiomes |
| Q97643856 | Microbial regulation of organismal energy homeostasis |
| Q57297579 | Microbiota and Phage Therapy: Future Challenges in Medicine |
| Q57479312 | Potential Application of Bacteriophages in Enrichment Culture for Improved Prenatal Screening |
| Q56334007 | Structural conservation in a membrane-enveloped filamentous virus infecting a hyperthermophilic acidophile |
| Q91725154 | Viruses and immunosenescence - more players in the game |
| Q93384575 | When pharmacology meets the microbiome: new targets for therapeutics? |
Search more.